While shares of stem cell company Athersys, Inc. (NASDAQ:ATHX) are trading up over 20% following new partnership agreement in Japan, shares of biotech company Caladrius Biosciences …
Athersys, Inc. (NASDAQ:ATHX) and Healios K.
Athersys, Inc. (NASDAQ:ATHX) announced hat multipotent adult progenitor cells (MAPC®), used in Athersys’ MultiStem® cell therapy currently in clinical development, are effective in improving …
Athersys, Inc. (NASDAQ:ATHX) announced its financial results for the three months ended September 30, 2015.
Athersys, Inc. (NASDAQ:ATHX) announced that Athersys and Chugai Pharmaceutical Co.
Recently, various executives have taken part in insider selling activity for the stocks of Athersys, Inc.(NASDAQ:ATHX), Neuralstem, Inc.
Athersys, Inc. (NASDAQ:ATHX) announced its financial and operating results for the three months ended June 30, 2015.
Recently, various executives have taken part in insider buying activity for the stocks of Opko Health Inc. (NYSE:OPK), Athersys, Inc.
Athersys, Inc. (NASDAQ:ATHX) announced its financial results for the three months ended March 31, 2015.
Maxim Group’s healthcare analyst Jason Kolbert weighed in with a few insights on Athersys, Inc. (NASDAQ:ATHX), after the company held a comprehensive call with …
